{"id":"NCT01253824","sponsor":"Nobelpharma","briefTitle":"Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers","officialTitle":"Pharmacodynamics of NPC-01( 1mg Norethisterone and 0.02mg Ethinyl Estradiol) and IKH-01( 1mg Norethisterone and 0.035mg Ethinyl Estradiol); Effect of NPC-01 and IKH-01 on Serum Concentrations of Estradiol, Progesterone, FSH and LH.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2010-12-03","resultsPosted":"2014-06-17","lastUpdate":"2025-03-06"},"enrollment":14,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Healthy"],"interventions":[{"type":"DRUG","name":"NPC-01","otherNames":["norethisterone and ethinyl estradiol"]},{"type":"DRUG","name":"IKH-01","otherNames":["norethisterone and ethinyl estradiol"]}],"arms":[{"label":"NPC-01","type":"EXPERIMENTAL"},{"label":"IKH-01","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the serum levels of estradiol, progesterone, FSH and LH in NPC-01 or IKH-01 one treatment cycle with those in before and after administration cycle.","primaryOutcome":{"measure":"Comparing Estradiol AUC of Menstrual Period During Study Drug Administration With Pre and Post Study Drug Administration (Baseline(BL)-Study Drug Administration(SDA), Follow up(FU)-Study Drug Administration(ADA))","timeFrame":"Day 3, 6, 9, 12, 15, 18, 21, 24 of menstrual cycles","effectByArm":[{"arm":"NPC-01","deltaMin":1654.7,"sd":1652.6},{"arm":"IKH-01","deltaMin":2478,"sd":793}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":["Metrorrhagia","Oligomenorrhoea","Nasopharyngitis","Abdominal pain","Menorrhagia"]}}